FDA product code HCH: Clip, Aneurysm

HCH is the FDA product code for clip, aneurysm. It is a Class II device, regulated under 21 CFR 882.5200 and reviewed by the Neurology panel. FDA has cleared 36 510(k) submissions under HCH, 1 in the last five years, from 18 different applicants. The average 510(k) review took 187 days (median 110). FDA has posted 4 recalls for HCH devices, 2 initiated in the last five years.

Classification

FieldValue
Device nameClip, Aneurysm
Device classClass II
Regulation21 CFR 882.5200
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)
ImplantYes

510(k) clearances per year for HCH

YearClearancesAvg. review days
20191386
20221316

Compare with all 510(k) review times · Search every HCH clearance

Top HCH applicants

ApplicantClearancesLatest
Aesculap, Inc.102014-01-24
Codman & Shurtleff, Inc.42009-09-08
Mizuho America, Inc.32022-03-02
Peter Lazic GmbH22019-04-12
V. Mueller Neuro/Spine22000-01-06

13 more applicants have HCH clearances. See the full list in Caduvo.

Most recent HCH clearances

510(k)ApplicantDeviceDecision dateReview days
K211183Mizuho America, Inc.Sugita AVM Microclips2022-03-02316
K180757Peter Lazic GmbHD-Clip; D-Clip Applier2019-04-12386
K131500Aesculap, Inc.YASARGIL ANEURYSM CLIPS AND CLIP APPLIERS2014-01-24245
K091921Codman & Shurtleff, Inc.CODMAN ANEURYSM CLIPS, CODMAN AVM MICRO CLIP SYSTEM, CODMAN SLIM-LINE GRAFT, REINFORCING, MINI ANEURYSM CLIP2009-09-0870
K081640Gimmi GmbHGIMMI ANEURYSM CLIPS AND APPLYING FORCEPS2009-05-06329

Recalls for HCH devices

4 product recalls in 2 recall events; 2 initiated in the last five years and 2 still open. Most recent: 2023-07-14.

YearRecalls
20232

Frequently asked questions

What is FDA product code HCH?

HCH is the FDA product code for clip, aneurysm. It is a Class II device, regulated under 21 CFR 882.5200 and reviewed by the Neurology panel.

What device class is HCH?

Class II, regulation 21 CFR 882.5200. Typical premarket route: 510(k).

How long does a 510(k) take for product code HCH?

Across 36 cleared submissions the average was 187 days from receipt to decision (median 110).

Which companies have the most HCH clearances?

Aesculap, Inc. (10); Codman & Shurtleff, Inc. (4); Mizuho America, Inc. (3); Peter Lazic GmbH (2); V. Mueller Neuro/Spine (2).

Have HCH devices been recalled?

Yes: 4 product recalls across 2 recall events; the most recent began 2023-07-14.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times